Ignite Creation Date:
2024-05-05 @ 11:12 PM
Last Modification Date:
2024-10-26 @ 10:30 AM
Study NCT ID:
NCT01276743
Status:
COMPLETED
Last Update Posted:
2014-02-28
First Post:
2011-01-12
Brief Title:
Study of PTPN22 C1858T Polymorphism in Children and Adolescents of Greek Origin With T1DM
Sponsor:
Aristotle University Of Thessaloniki
Organization:
Aristotle University Of Thessaloniki
Study Overview
Official Title:
Study of Protein Tyrosine Phosphatase Non-receptor Type 22 PTPN22 C1858T Polymorphism in Children and Adolescents of Greek Origin With Type 1 Diabetes Mellitus T1DM
Status:
COMPLETED
Status Verified Date:
2014-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The protein tyrosine phosphatase non-receptor type 22 PTPN22 gene encodes a lymphoid-specific phosphatase LYP which is an important downregulatory factor of T cell activation A PTPN22 polymorphism C1858T was found associated with T1DM in different Caucasian populations
In this observational case-control study we aimed at confirming the role of PTPN22 C1858T polymorphism in T1DM predisposition in a Greek population
In this observational case-control study we aimed at confirming the role of PTPN22 C1858T polymorphism in T1DM predisposition in a Greek population
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None